Prostate cancer mortality predictions for Ireland up to 2015

European Journal of Cancer Prevention

Volumn 16, Issue 4, 2007, Pages 328-333

  O'Lorcain, Piaras ^a   Comber, Harry ^a  

^a NATIONAL CANCER REGISTRY IRELAND   (Ireland)

Author keywords

Ireland; Log and log linear Poisson regression modelling; Predictions; Prostate cancer; Trends

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER MORTALITY; CHILD; DATA ANALYSIS; HUMAN; INFANT; IRELAND; LINEAR REGRESSION ANALYSIS; LOGLINEAR MODEL; MAJOR CLINICAL STUDY; MALE; NEWBORN; POISSON DISTRIBUTION; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; HUMANS; INFANT; INFANT, NEWBORN; IRELAND; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; TIME FACTORS; WORLD HEALTH ORGANIZATION;

EID: 34547415991     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cej.0000236248.63489.4c     Document Type: Article

References (23)

1. Catalona WJ, Smith DS, Ratliff TL, Basler JW (1993). Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 270:948-954.
2. Central Statistics Office (1950-2002). Annual report on vital statistics (1950 to 2002). Dublin: Government Publications Office.
3. Central Statistics Office (1951-2002). Irish census data 1951, 1956, 1961, 1966, 1971, 1979, 1986, 1991, 1996, 2002. Dublin: Goverment Publications Office.
4. Central Statistics Office (2004). Irish population and labour projections 2002-2036 (2004). Dublin: Goverment Publications Office.
5. Coldman AJ, Phillips N, Pickles TA (2003). Trends in prostate cancer incidence and mortality: an analysis of mortality change by screening intensity. Can Med Assoc J 168:31-35.
6. Cox DR, Hinkley DV (1990). Theoretical statistics. London: Chapman and Hall.
7. Crocetti E, Ciatto S, Zappa M (2000). Prostate cancer: different incidence but not mortality trends within two areas of Tuscany, Italy. J Natl Cancer Inst 92:1873-1876.
8. Department of Health and Children (1996). Cancer services in Ireland: a national strategy. Dublin: Government Publications Office.
9. Gann PH, Hennekens CH, Stampfer MJ (1995). A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA 273:289-294.
10. Hakulinen T (1996). The future cancer burden as a study subject. Acta Oncol 35:665-670.
11. Hakulinen T (2000). Breast cancer: modelling of mortality trends. In: Sankila R, Démaret E, Hakama M, Lynge E, Schouten LJ, Parkin DM, editors. Evaluation and monitoring of screening programmes. Brussels-Luxembourg: European Network of Cancer Registries, European Commission, Europe Against Cancer Programme; pp. 151-162.
12. International Agency for Research on Cancer (2005). Cancer mortality databank. Available at: http://www.dep.iarc.fr/ [Accessed in March 2005].
13. JoinPoint Regression Programme (Version 2.5). US National Cancer Institute of Health, July 2000. Available at: http://www.dccps.ims.nci.nih.gov/ SRAB/joinpoint/.
14. Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000). Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335-351.
15. Labrie F, Candas B, Cusan L, Gomez JL, Belanger A, Brousseau G, et al. (2004). Screening decreases prostate cancer mortality: 11-year follow-up of the 1980 Quebec prospective randomised controlled trial. Prostate 59:311-318.
16. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C (2004). Leveling of prostate cancer mortality in Western Europe. Prostate 60:46-52.
17. National Cancer Registry (2004). Cancer in Ireland, 1994-2000 (2004). Incidence, mortality, treatment and survival. Cork: National Cancer Registry.
18. Neal DE, Leung HY, Powell PH, Hamdy FC, Donovan JL (2000). Unanswered questions in screening for prostate cancer. Eur J Cancer 36:1316-1321.
19. Oliver SE, Gunnell D, Donovan JL (2000). Comparison of trends in prostate-cancer mortality in England and Wales and the USA. Lancet 355:1788-1789.
20. Perron L, Moore L, Bairati I, Bernard PM, Meyer F (2002). PSA screening and prostate cancer mortality. Can Med Assoc J 166:586-591.
21. Slevin S (2004). Statistical analysis of epidemiologic data (monographs in epidemiology & biostatistics). 3rd ed. USA: Oxford University Press Inc. pp. 23-25.
22. World Health Organisation (1977). International statistical classification of diseases and related health problems. 9th revision. Geneva: World Health Organisation.
23. Yatani K, Chigusa I, Akazaki K, Stemmermann GN, Welsh RH, Correa P (1982). Geographic pathology of latent prostatic carcinoma. Int J Cancer 29:611-616.